Increase Lean Body Mass – Demonstrated increase in Lean Body Mass. (Chen et al., 2005) Improve Skeletal Muscle Strength – Ability to improve skeletal (soleus) Muscle Strength. (Gao et al., 2007) Reduce Body Fat– Demonstrated reduced body fat in subjects. (Kearbey et al., 2007)
Increase Muscle Mass - Showed an increase in fat-free (Svensson, et al., 1998) Prevent Muscle Loss - Able to reverse diet-induced catabolism (Murphy, et al., 1998) Better Brain Function - IGF-1 can improve memory (Aleman, et al., 1999) Improve Sleep Quality - Rapid Eye Movement (REM) Sleep duration was increased (Copinschi, et al., 1997)
Increase Muscle Mass - Showed significant lean muscle mass increase (Basaria, et al., 2013) Higher Anabolic Response - Improved ligand efficiency with specific targeting (Handlon, et al., 2015) Minimal Side effects - As a result of its selectivity, LGD-4033 showed no side effects in subjects (Basaria, et al., 2013)
Increase Muscle Mass - Showed significant lean muscle mass increase (Evans et al., 2007) Increased Fat Loss -Improved fat loss after 84 days (Dalton et al, 2008) Improved Bone Strength - Helps to stimulate bone formation (Furuya, 2011)
Increase Lean Muscle Mass – Cell studies showed strong bonds with androgen receptors. (Jones A, et al., 2009). Retain Muscle Mass - S-23 inhibited muscle loss (Jones et al., 2010). Decrease Fat Mass– Subjects experienced a decrease in fat mass. (Jones A, et al., 2009).
Increase Muscle Mass– Anabolic androgenic ratio of 80:1. Improve Strength– High anabolic ratio leads to substantial strength gains. Improve Memory – Effective against androgen-responsive tissue related disease. Making it neuroprotective and helps improve cognitive function.
Increased Muscle Size - Cell studies show an increase in muscle size through myostatin inhibition (Y. Kanno, et al., 2013) Stronger Bones - Increased levels of activated PKB increases bone growth signalling (T. Yatsu, et al., 2018)